Cleared Traditional

K993229 - ANALGESIC PULSER, MODEL AP-439

K993229 is an FDA 510(k) clearance for ANALGESIC PULSER, manufactured by Johari Electro-Tech Co.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 494-day FDA review.

K993229 · Johari Electro-Tech Co. · Neurology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Feb 2001
Decision
494d
Days
Class 2
Risk

K993229 is an FDA 510(k) clearance for the ANALGESIC PULSER, MODEL AP-439. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Johari Electro-Tech Co. (Jodhpur-342003, IN). The FDA issued a Cleared decision on February 2, 2001 after a review of 494 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

FDA 510(k) Submission Details - K993229

510(k) Number K993229 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 27, 1999
Decision Date February 02, 2001
Days to Decision 494 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
PCCP Authorized No
Regulatory Context
Review time vs. panel average
345d slower than avg
Panel avg: 149d · This submission: 494d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 546
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K993229.
LIFECARE COMPACT TENS DEVICE
K003369 · Lifecare , Ltd. · Mar 2001
MEDRELIEF
K003507 · Healthonics, Inc. · Feb 2001
TENSCARE, MODEL TENS XL-2
K003591 · Tenscare, Ltd. · Feb 2001
STIMATE N601 TENS
K003487 · Everyway Medical Instruments Co.,Ltd · Jan 2001
HMS NEUROMUSCULAR STIMULATOR, MODEL HMS 3
K003231 · Home Medical Services · Jan 2001
MS-ONE, MODEL MS-1
K003258 · Home Wellness West · Jan 2001
K993229 · ANALGESIC PULSER, MODEL AP-439
Download PDF FDA Summary Johari Electro-Tech C…